A 42-year-old woman gained weight from early menopause and a stressful job. She lost over 60 pounds with 3 habits.
When she started a new job, she joined a health app paid for through work.
Walking every day, logging her water intake, and meal swaps helped her lose over 60 pounds.
At 40, Michelle Kloese felt like she didn't recognize her body. In five years, she gained 38 pounds and developed high cholesterol, high blood sugar, and plantar fasciitis, a kind of foot pain caused by inflammation.
She didn't always feel like this. In her 20s, running was her main form of exercise, and she loved 5K races. Her body started to change in her mid-20s, when she experienced symptoms of early menopause, like infertility. By her 30s, bloodwork confirmed she had perimenopause, around 15 years earlier than most women.
Then, in her mid-30s, she started a demanding job as a middle school assistant principal, often starting before the school day and wrapping up after school hours. With less time to work out, a busy schedule, and irregular meals, she started to snack more.
"Somebody would leave a cupcake on my desk, so I'd eat that, or parents would bring in a basket of candy," Kloese, now 42, told Business Insider.
The change in her body really struck her after a surprise trip to Ireland for her 40th birthday. "I looked at the pictures and went, 'Oh gosh, I need to do something different,'" she said.
She had just started a new, less stressful edtech job, Kloese learned about a health app, Personify Health, connected through their insurance. The timing was perfect: she signed up, logging her steps and water intake.
She lost 38 pounds in the first year and 23 pounds the following year. Now she's in a "weight maintenance" phase, seeking to stay within a few pounds of her current weight.
"I have so much more energy — I'm not as sluggish and tired as I was feeling all the time," she said. The issues related to her weight, like high cholesterol and high blood pressure, also went away. "I have just felt a whole lot better."
Kloese shared the three habits she started and still maintains to keep the weight off.
Before, Kloese didn't drink much water — sometimes, she'd only remember to have around eight ounces of the recommended eight cups in one day. "That's one of the most challenging ones for me to do," she said.
Her goal was to get to at least 72 ounces, or nine cups per day.
Tracking her intake helped. The first thing she did every morning was drink a full, 8-ounce glass of water and log it in the app. For the rest of the day, she'd log in "steady sips", using a marked water bottle to measure her progress. It was more manageable for her to track two ounces at a time rather than feel pressure to chug a lot of water at once.
Drinking water helps with weight loss by curbing your appetite. It can also help you reach a calorie deficit if you swap it for high-calorie drinks like soda.
While she used to run a lot in her 20s, Kloese's knees and hips hurt when she tried in her 40s. She knew she needed to try something different.
When she first made a plan to lose weight, Kloese communicated with a personal trainer through an app. The trainer said that, in her 40s, it was important for Kloese to focus on strength training as we naturally lose muscle with age. Muscle-building can also help with weight loss — gaining muscle boosts your metabolism and burns fat.
Kloese started doing at-home and online circuit workouts 3-4 times a week with light weights.
The rest of the time, she walked. She took part in a fitness challenge of walking 30 minutes a day. Weight-loss-wise, she said she saw about the same results as running.
Now, she aims to walk at least 7,000 steps a day, whether on her walking pad or on trails near her home in Florida. Occasionally, she trains for Mammoth Marches, 20-mile hikes all over the country.
She also swapped out some of the strength training with yoga, which relaxes her while still improving her strength and flexibility.
Being more active transformed her relationships with her friends. "Before, where we might've just picked a restaurant to hang out at, instead, we go out and do a hike," she said.
Despite snacking on sugary treats at her old job, Kloese isn't much of a sweets person. "I was a pasta-potato-bread kind of person," she said. Still, she wanted to make some more nutritious swaps.
Through the KickStart app, she logged her meals by taking photos of them. If she got a burger and fries, the app suggested lower-carb sides for next time, like a side salad or sweet potato wedges.
Eventually, she naturally made those swaps on her own, like cooking quinoa instead of white rice. She also gets pre-made meals through Factor, which she said helps her with portion control and eating a balanced diet when she's busy.
"Those were all small changes that evolved over time," she said.
Read the original article on Business Insider
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Cedars-Sinai's AI tool delivered 24/7 care to 42,000 patients. Now, doctors can focus more on treatment, less on paperwork.
Cedars-Sinai launched CS Connect, an AI-powered platform for 24/7 healthcare support. The platform aims to reduce wait times and administrative tasks, improving care delivery. This article is part of "CXO AI Playbook" — straight talk from business leaders on how they're testing and using AI. Cedars-Sinai is a nonprofit healthcare organization based in Los Angeles. It's comprised of hospitals, clinics, and research facilities. Founded in 1902, Cedars-Sinai has more than 40 locations, employs over 4,500 physicians and nurses, and serves more than 1 million patients every year. Situation analysis Caroline Goldzweig, chief medical officer of Cedars-Sinai Medical Network, told Business Insider that the organization wanted to expand patients' access to primary care in a more efficient and convenient way. For instance, sometimes there are lengthy wait times for in-person doctor's appointments. At the same time, Goldzweig said the organization was looking to reduce the administrative burden on physicians, including patient intake and data entry, so that they could focus on providing care. To address these challenges, the organization launched Cedars-Sinai Connect in 2023. CS Connect is an artificial intelligence-powered virtual platform where patients can access healthcare support 24/7. Goldzweig said the AI technology allows healthcare providers to better support their patients while improving the speed of care delivery. "The other exciting thing is the ability to offer patients care in ways that meet their needs," she said. Key staff and partners Goldzweig told Business Insider that CS Connect was built using K Health, a digital healthcare company providing AI-powered primary and urgent care services. Cedars-Sinai's information technology teams worked with K Health to sync patients' electronic health records into the platform, she said. Cedars-Sinai's enterprise data intelligence and digital strategy teams were also involved in creating CS Connect. They continue to help manage it. AI in action The goal of the AI tool is to enable providers to spend more time counseling patients and making treatment decisions, rather than doing patient intake. To access the AI features, patients log into CS Connect via a mobile app or its website. Goldzweig said a chat feature then starts asking the user questions about their symptoms. The AI algorithm compares the patient's responses to their existing medical records and the records of other patients in the system who had similar symptoms. It then asks more detailed questions about a patient's specific health problems. The chatbot, for example, may prompt the patient to submit photos of their sore throat or rash. Goldzweig said the chat function is similar to how a physician might identify a patient's ailment. The AI then summarizes the patient's information — a task that usually demands manual effort from physicians — and recommends a treatment. The data collected by CS Connect is "part of the efficiency process," Goldzweig said. "It allows the physicians to review it, to understand what's going on, and to validate things with the patient — ask a couple of clarifying questions and maybe get a little bit more history." Physicians can choose to disagree with the AI's recommendations. Goldzweig said either way, they're required to sign off on each patient's treatment plan. Did it work, and how did leaders know? Goldzweig told BI that about 42,000 individual patients have used CS Connect. In April 2025, Cedars-Sinai published a study in the journal Annals of Internal Medicine comparing AI treatment recommendations in CS Connect with final recommendations from doctors. The study reviewed 461 physician-managed visits with AI recommendations for respiratory, urinary, vaginal, eye, and dental symptoms. Results showed that when AI and physician recommendations differed, the AI suggestions were often rated as higher quality. The study found that 77% of AI recommendations were rated as optimal, while 67% of physicians' decisions were rated optimal. For example, patients with recurring urinary tract infections sometimes encounter antibiotic resistance. Goldzweig said the AI was successful at identifying these patients and recommended a bacterial culture before prescribing antibiotics. In contrast, doctors sometimes prescribe medication without testing, which she said could result in the infection coming back. Goldzweig added that the study suggests that the AI tool tends to be more guideline-focused, while physicians have the ability to adapt medical guidelines based on the nuance of a patient's case. Goldzweig said the study has limitations, though. It examined only a few medical conditions and didn't factor in the nuance of individual patient cases. Another limitation is that the medical chart reviewers could see whether the recommendation was made by the AI or a physician. Cedars-Sinai is working to expand CS Connect. The organization is piloting remote patient monitoring technology using AI to help people manage chronic diseases, like high blood pressure. It's also planning to use the AI technology to connect in-person urgent care visits with virtual care. Read the original article on Business Insider
Business Insider
2 days ago
- Business Insider
Cedars-Sinai's AI tool delivered 24/7 care to 42,000 patients. Now, doctors can focus on treatment, not paperwork.
Cedars-Sinai launched CS Connect, an AI-powered platform for 24/7 healthcare support. The platform aims to reduce wait times and administrative tasks, improving care delivery. This article is part of " CXO AI Playbook" — straight talk from business leaders on how they're testing and using AI. Cedars-Sinai is a nonprofit healthcare organization based in Los Angeles. It's comprised of hospitals, clinics, and research facilities. Founded in 1902, Cedars-Sinai has more than 40 locations, employs over 4,500 physicians and nurses, and serves more than 1 million patients every year. Situation analysis Caroline Goldzweig, chief medical officer of Cedars-Sinai Medical Network, told Business Insider that the organization wanted to expand patients' access to primary care in a more efficient and convenient way. For instance, sometimes there are lengthy wait times for in-person doctor's appointments. At the same time, Goldzweig said the organization was looking to reduce the administrative burden on physicians, including patient intake and data entry, so that they could focus on providing care. To address these challenges, the organization launched Cedars-Sinai Connect in 2023. CS Connect is an artificial intelligence -powered virtual platform where patients can access healthcare support 24/7. Goldzweig said the AI technology allows healthcare providers to better support their patients while improving the speed of care delivery. "The other exciting thing is the ability to offer patients care in ways that meet their needs," she said. Key staff and partners Goldzweig told Business Insider that CS Connect was built using K Health, a digital healthcare company providing AI-powered primary and urgent care services. Cedars-Sinai's information technology teams worked with K Health to sync patients' electronic health records into the platform, she said. Cedars-Sinai's enterprise data intelligence and digital strategy teams were also involved in creating CS Connect. They continue to help manage it. AI in action The goal of the AI tool is to enable providers to spend more time counseling patients and making treatment decisions, rather than doing patient intake. To access the AI features, patients log into CS Connect via a mobile app or its website. Goldzweig said a chat feature then starts asking the user questions about their symptoms. The AI algorithm compares the patient's responses to their existing medical records and the records of other patients in the system who had similar symptoms. It then asks more detailed questions about a patient's specific health problems. The chatbot, for example, may prompt the patient to submit photos of their sore throat or rash. Goldzweig said the chat function is similar to how a physician might identify a patient's ailment. The AI then summarizes the patient's information — a task that usually demands manual effort from physicians — and recommends a treatment. The data collected by CS Connect is "part of the efficiency process," Goldzweig said. "It allows the physicians to review it, to understand what's going on, and to validate things with the patient — ask a couple of clarifying questions and maybe get a little bit more history." Physicians can choose to disagree with the AI's recommendations. Goldzweig said either way, they're required to sign off on each patient's treatment plan. Did it work, and how did leaders know? Goldzweig told BI that about 42,000 individual patients have used CS Connect. In April 2025, Cedars-Sinai published a study in the journal Annals of Internal Medicine comparing AI treatment recommendations in CS Connect with final recommendations from doctors. The study reviewed 461 physician-managed visits with AI recommendations for respiratory, urinary, vaginal, eye, and dental symptoms. Results showed that when AI and physician recommendations differed, the AI suggestions were often rated as higher quality. The study found that 77% of AI recommendations were rated as optimal, while 67% of physicians' decisions were rated optimal. For example, patients with recurring urinary tract infections sometimes encounter antibiotic resistance. Goldzweig said the AI was successful at identifying these patients and recommended a bacterial culture before prescribing antibiotics. In contrast, doctors sometimes prescribe medication without testing, which she said could result in the infection coming back. Goldzweig added that the study suggests that the AI tool tends to be more guideline-focused, while physicians have the ability to adapt medical guidelines based on the nuance of a patient's case. Goldzweig said the study has limitations, though. It examined only a few medical conditions and didn't factor in the nuance of individual patient cases. Another limitation is that the medical chart reviewers could see whether the recommendation was made by the AI or a physician. Cedars-Sinai is working to expand CS Connect. The organization is piloting remote patient monitoring technology using AI to help people manage chronic diseases, like high blood pressure. It's also planning to use the AI technology to connect in-person urgent care visits with virtual care.
Business Insider
2 days ago
- Business Insider
Colonoscopies are no fun. These at-home colon cancer screenings offer a shortcut.
Colon cancer is the second-deadliest cancer in America. It's not deadly because it's particularly hard to treat or because oncologists are bad at spotting it. In large part, it's because people aren't getting their colon checked out often enough. Only about 1 in 5 adults who are between the ages of 45 and 49 is up to date on their colon cancer screening (older adults fare better, with around 7 in 10 completing it). "This is a highly preventable disease and we have to change the status quo so that people don't die," Dr. Paul Limburg, a gastroenterologist and chief medical officer at Exact Sciences, the company that makes one of the most popular do-it-yourself colon cancer screening tests, told Business Insider. A colonoscopy is still the most reliable tool, both for spotting colon cancer and for serving double duty as a colon-cleanup service. "I would still choose a colonoscopy for myself," Dr. Tim Cannon, a medical oncologist who directs the gastrointestinal cancer program at the Inova Schar Cancer Institute, told BI. "It is considered the gold standard, you can detect precancerous polyps and take them out during the procedure, and you can do it less often" than DIY tests, Cannon said. However, a new suite of at-home tests is rapidly expanding. For those struggling to find an appointment, those who don't have great insurance, or those who are just squeamish about colonoscopies, there are some pretty painless precursors you can do to check things out. Some recently-approved tests check your blood or your stool for signs that something is awry. One highly anticipated test, which isn't out yet, may require nothing more than your breath. The budget-friendly original: an at-home FIT test The fecal immunochemical test (aka FIT) has been around since the 1980s and is still a recommended screening tool today because it's cheap, relatively reliable, and requires no preparation. "Fecal-immuno test is the most inexpensive," Dr. Asad Umar previously told BI. "People don't like to do it, because — maybe it's the 'yuck' factor — but this could be lifesaving." You typically perform the FIT in your bathroom after a bowel movement by collecting some stool out of the toilet bowl with a brush. After the kit is sent to the lab, it will be checked for hidden blood in the stool — an early colon cancer symptom. Since colon cancers don't constantly let out blood in your stool, the test isn't perfect. FIT is about 75% accurate at detecting colon cancer cases, and a smaller number of people (about 1 in 20) may get a false positive result when they don't have colon cancer. The pooper scooper: Cologuard stool testing Like FIT, Cologuard is a stool test that you do in the bathroom, and then send into a lab for testing. Unlike FIT, Cologuard looks for both blood and cancerous DNA in your poop. Adding DNA to the mix makes Cologuard more successful: it picks up more than 9 in 10 colon cancer cases, and can flag some precancerous polyps. The downside is that Cologuard also sometimes flags poop samples that aren't cancerous, with roughly 1 in 10 patients receiving a false positive test reading. Anne Jones, a collegiate athlete career coach, was 46 when she first tried Cologuard. She knew that more women her age were being diagnosed with late-stage colon cancers, but she was hesitating about when to schedule her first colonoscopy. Did she really need to do this right now? A colonoscopy procedure requires several hours of prep work at home, emptying out your colon with heavy-duty laxatives. It's performed under anesthesia, so you need someone to pick you up from the hospital afterward. "It was less the fear of the colonoscopy and more just the hassle," Jones said. When her doctor explained she could order a Cologuard test and do it on her own at home with zero prep, it seemed like a no-brainer. "The doer in me is like 'great, let's do it.' I want to get this done. Cross it off the list." Crossing her colon cancer screening "off the list" ended up taking a few more steps, though, because Jones's Cologuard test came back positive. Within a few months, Jones went in for a colonoscopy, which found and removed multiple pre-cancerous polyps in her colon. "It was not cancer, but there were three polyps that were pre-cancerous," Jones said. She said she's glad she was given the nudge to go under, though. "It just begs the question, if I had waited a year, might that have been different?" Cologuard, made by Exact Sciences, was first approved in 2014. In late 2024, the US Food and Drug Administration approved Cologuard Plus, which is more accurate than the regular Cologuard test and detects around 95% of colon cancers. The blood draw: Guardant Guardant Health has a new cancer screening test that skips the toilet and goes straight to your blood, analyzing your DNA for tell-tale clues that cancer could be lurking. "What you're detecting is an abnormal molecule that is only created by a cancer," Guardant's Chief Medical Officer Dr. Craig Eagle told BI. "The more we learn what that looks like, the more we can actually find smaller and smaller amounts." Guardant's first colon cancer blood test, called Shield, was FDA-approved in July 2024. It's part of the company's suite of "liquid biopsies" that use blood to help doctors gain insights about cancer, whether for cancer diagnosis or in later stages to inform cancer treatment decisions. Guardant CEO Helmy Eltoukhy told BI he hopes that Shield can soon be harnessed to identify even more cancers, including some that are notoriously hard to detect, like pancreatic cancer. One federally funded study is recruiting 24,000 people across the US to test out Shield on multiple cancers. "That's the beauty of this test: think of it as your iPhone, where initially it only had a few features. Over time, it has a thousand features," Eltoukhy told BI. Patricia James, now 77, was one of the first patients to try Shield in Guardant's pivotal clinical trial that ultimately led to its FDA approval last year. As a cancer survivor with a family history of colon cancer, she is a big believer in preventative care. But she doesn't really like colonoscopies, having had a rare but really bad experience during her first, when she woke up halfway through the procedure, and started "crashing around" on the operating table. After that, she said, she essentially swore off colonoscopies. She's getting older and has a greater risk of internal tearing and other rare complications from the procedure. So when her doctor mentioned there was a blood test available to screen for colon cancer, she said "sure." "There was no extra doctor's visit or anything," James told BI. She did it while she was in for a regular mammogram visit. She's now a huge advocate for the test, and even gave video testimony to Congress before it was FDA-approved. "Look, I don't ever wanna mess around with my health, I've lost people to cancer and I battled it myself," she told the lawmakers. "I'm someone who wants all the time in the world to keep living. I have sung the praises of this test to friends and look forward to getting it again." Like the other screening tests mentioned here, Shield does have a risk of false-positive and false-negative results, but those inaccuracies decrease as cancer progresses. In other words, the further along cancer is, the better the test is at detecting it. Method: Blood How often: Once every three years Cost: Generally covered by insurance for those over 45, and by Medicare for older adults. The test costs around $1,500 out-of-pocket. Pros: No poop involved Cons: Requires a doctor's visit to collect blood. Also,roughly 1 of every 10 patients who don't have colon cancer may receive a false positive result, and 1 in 6 who do have cancer may receive a false negative. The breath test for colon cancer Imagine that instead of collecting blood or poop to screen for colon cancer, all you have to do is breathe out for a few minutes. Several companies, in the UK, US, Canada, and Israel are working on innovative cancer screening tests that would pick up on volatile organic compounds in your breath. It's essentially like an emissions test for cancer. While none of these are available yet, the Israeli-based startup SpotitEarly is hoping to make its test available to consumers in the US as early as 2026, if all goes well with FDA regulators. A company-sponsored study published in November suggests the test is about 86% effective at picking up early-stage colon cancer cases (Stage 1 and 2).
